11
Participants
Start Date
February 25, 2016
Primary Completion Date
October 1, 2017
Study Completion Date
January 31, 2018
First Intervention (14 days)
Oral Glutamine or Maltodextrin for 2 weeks
Washout (3 weeks)
No study product is taken prior to beginning crossover
Second Intervention (14 days)
Oral Glutamine or Maltodextrin for 2 weeks
Kidney Research Institute, University of Washington, Seattle
Collaborators (1)
New York Medical College
OTHER
Emory University
OTHER
Vanderbilt University
OTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
University of Washington
OTHER